Source:http://linkedlifedata.com/resource/pubmed/id/18189347
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-2-8
|
pubmed:abstractText |
Malaria, caused by Plasmodia parasites, has re-emerged as a major problem, imposing its fatal effects on human health, especially due to multidrug resistance. In Plasmodia, orotidine 5'-monophosphate decarboxylase (ODCase) is an essential enzyme for the de novo synthesis of uridine 5'-monophosphate. Impairing ODCase in these pathogens is a promising strategy to develop novel classes of therapeutics. Encouraged by our recent discovery that 6-iodo uridine is a potent inhibitor of P. falciparum, we investigated the structure-activity relationships of various C6 derivatives of UMP. 6-Cyano, 6-azido, 6-amino, 6-methyl, 6- N-methylamino, and 6- N, N-dimethylamino derivatives of uridine were evaluated against P. falciparum. The mononucleotides of 6-cyano, 6-azido, 6-amino, and 6-methyl uridine derivatives were studied as inhibitors of plasmodial ODCase. 6-Azidouridine 5'-monophosphate is a potent covalent inhibitor of P. falciparum ODCase. 6-Methyluridine exhibited weak antimalarial activity against P. falciparum 3D7 isolate. 6- N-Methylamino and 6- N, N-dimethylamino uridine derivatives exhibited moderate antimalarial activities.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
439-48
|
pubmed:meshHeading |
pubmed-meshheading:18189347-Animals,
pubmed-meshheading:18189347-Antimalarials,
pubmed-meshheading:18189347-CHO Cells,
pubmed-meshheading:18189347-Cricetinae,
pubmed-meshheading:18189347-Cricetulus,
pubmed-meshheading:18189347-Crystallography, X-Ray,
pubmed-meshheading:18189347-Models, Molecular,
pubmed-meshheading:18189347-Orotidine-5'-Phosphate Decarboxylase,
pubmed-meshheading:18189347-Plasmodium,
pubmed-meshheading:18189347-Plasmodium falciparum,
pubmed-meshheading:18189347-Plasmodium vivax,
pubmed-meshheading:18189347-Structure-Activity Relationship,
pubmed-meshheading:18189347-Uridine,
pubmed-meshheading:18189347-Uridine Monophosphate
|
pubmed:year |
2008
|
pubmed:articleTitle |
Structure-activity relationships of C6-uridine derivatives targeting plasmodia orotidine monophosphate decarboxylase.
|
pubmed:affiliation |
Center for Molecular Design and Preformulations and Division of Cell and Molecular Biology, Toronto General Research Institute/University Health Network, MaRS/TMDT, Toronto, ON, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|